Rafferty Asset Management, LLC - CYRUSONE INC ownership

CYRUSONE INC's ticker is CONE and the CUSIP is 23283R100. A total of 469 filers reported holding CYRUSONE INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.4%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of CYRUSONE INC
ValueSharesWeighting
Q4 2021$621,000
-2.1%
6,917
-15.5%
0.00%
-25.0%
Q3 2021$634,000
-10.6%
8,187
-17.4%
0.00%0.0%
Q2 2021$709,000
+65.3%
9,914
+56.5%
0.00%
+33.3%
Q1 2021$429,000
+39.7%
6,335
+51.0%
0.00%0.0%
Q4 2020$307,000
-52.2%
4,195
-54.3%
0.00%
-62.5%
Q3 2020$642,000
-67.8%
9,173
-66.5%
0.01%
-71.4%
Q2 2020$1,993,000
+589.6%
27,395
+485.2%
0.03%
+133.3%
Q1 2020$289,000
-79.4%
4,681
-78.2%
0.01%
-45.5%
Q4 2019$1,403,000
-9.8%
21,437
+9.0%
0.02%
-8.3%
Q3 2019$1,555,000
+26.0%
19,659
-8.0%
0.02%
+9.1%
Q2 2019$1,234,000
-2.8%
21,371
-11.7%
0.02%
+10.0%
Q1 2019$1,270,000
+16.9%
24,215
+18.0%
0.02%
-16.7%
Q4 2018$1,086,000
-78.8%
20,529
-74.6%
0.02%
-69.6%
Q3 2018$5,116,000
+197.6%
80,692
+174.0%
0.08%
+203.8%
Q2 2018$1,719,000
+45.9%
29,451
+28.0%
0.03%
+52.9%
Q1 2018$1,178,000
+0.5%
23,003
+16.9%
0.02%
-15.0%
Q4 2017$1,172,000
+37.6%
19,680
+36.1%
0.02%
+5.3%
Q3 2017$852,000
+19.0%
14,461
+12.6%
0.02%
-9.5%
Q2 2017$716,000
+8.6%
12,841
+0.2%
0.02%
+40.0%
Q1 2017$659,000
+205.1%
12,812
+182.6%
0.02%
+87.5%
Q3 2016$216,000
-49.1%
4,534
-40.5%
0.01%
-72.4%
Q2 2016$424,0007,6180.03%
Other shareholders
CYRUSONE INC shareholders Q4 2021
NameSharesValueWeighting ↓
SEVEN LOCKS CAPITAL MANAGEMENT LP 1,295,011$31,132,0004.40%
ALTEGRIS ADVISORS, L.L.C. 136,001$3,269,0003.63%
TREMBLANT CAPITAL GROUP 1,584,607$38,094,0001.36%
TriOaks Capital Management L.P. 117,300$2,820,0001.21%
WALL STREET ASSOCIATES 339,975$8,173,0000.84%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 133,479$3,209,0000.84%
HEITMAN REAL ESTATE SECURITIES LLC 501,862$12,065,0000.80%
PALISADE CAPITAL MANAGEMENT, LP 808,912$19,446,0000.49%
CHILTON CAPITAL MANAGEMENT LLC 181,000$4,351,0000.46%
River Road Asset Management, LLC 1,311,098$31,519,0000.44%
View complete list of CYRUSONE INC shareholders